Paris Saint-Germain manager Thomas Tuchel has revealed he’s keen to buy players when the transfer window reopens in January.The former Borussia Dortmund boss is keen to see his midfield options strengthened after playing makeshift players in that position, as the French champions struggle with lack of options in the middle of the park.“That is very simple — I would like a second Marco or a second Marquinhos,” Tuchel said, according to ESPN.“However, first of all, we need to find this person. We want guys with good mentality, and that is hard to find.”Asked about goalkeeper Alphonse Areola’s decision to extend his contract with the French champions until 2023, Tuchel praised the France international.Merson believes Arsenal should sign Sancho Manuel R. Medina – September 14, 2019 Borussia Dortmund winger Jadon Sancho might be the perfect player to play for the Gunners, according to former England international Paul Merson.“Alphonse is very important for us,” he said. “He has always said: ‘This is my club — I want to stay.’ It is really important to have guys like that — it is a strong signal.”Areola, who revealed Tuchel had played a major role in convincing him to commit his long-term future to Le Parisians, said he had not discussed Adrien Rabiot’s situation with his teammate.The French midfielder has been linked with a move away from Paris with Barcelona and Liverpool rumored to be interested in his services.“I have not really spoken with Adrien about it,” he said. “It is between him and the club, so it is not my business.”
JBL Flip The new JBL Flip 5 in front of the Flip 4. It’s really only a little bigger than its predecessor. David Carnoy/CNET Lay the JBL Flip 5 next to last year’s Flip 4 like I did at this year’s CES in Las Vegas and you’ll notice that the Flip 5 looks pretty similar but is slightly bigger than its predecessor. That increased size has allowed JBL’s engineers to equip the Flip 5 with a larger battery and more power so that it delivers a little bigger sound. It also now has USB-C charging for quicker battery charging. Like its predecessor, the JBL Flip 5 is fully waterproof, has a buillt-in microphone for speakerphone calls and comes in multiple color options. It’ll ship this spring for $100 and should gradually come down in price over the course of the year.I’ll have a full review shortly before it hits stores. Enlarge ImageAll the new color options. David Carnoy/CNET JBL Flip 5 key features Wireless Bluetooth streaming: Wirelessly connect to any smartphone or tablet with BluetoothBuilt-in 4800mAh rechargeable Li-ion battery supports up to 12 hours of continuous playtimeIPX7 Waterproof: Can be fully submersed in waterImproved bass performanceUSB-C chargingBuilt-in speakerphone allows you to take calls with the touch of a buttonPrice: $100Shipping this spring Enlarge ImageNow with USB-C charging! David Carnoy/CNET Review • JBL Flip review: Portable Bluetooth speaker stands tall Tags Wireless & Bluetooth Speakers See it $119 1:07 Now playing: Watch this: CES 2019 CES 2019: See all of CNET’s coverage of the year’s biggest tech show. CES schedule: It’s six days of jam-packed events. Here’s what to expect. Share your voice Comment Mentioned Above JBL Flip (white) CES Products Bluetooth Some of the most anticipated tech for 2019 CNET may get a commission from retail offers. 1
Share Listen 00:00 /00:49 To embed this piece of audio in your site, please use this code: Andrew Schneider/Houston Public MediaLizzie Pannill Fletcher (D) and Congressman John Culberson (R) debated Sunday evening at the University of Houston.Republican Congressman John Culberson and Democratic candidate Lizzie Pannill Fletcher are neck and neck in the last days of the race.Culberson is running largely on two messages: Fletcher is too liberal, and he’s the one who brought Houston billions of dollars for disaster relief.“Obviously, there’s going to be a lot of focus on the Harvey recovery and certainly, to his benefit, the role that he played in that recovery as a senior appropriator,” says Tony Essalih, formerly Culberson’s chief of staff, now principal and director of Cornerstone Government Affairs’ Houston office.But Jon Taylor, professor of political science at the University of Saint Thomas, says Fletcher presents a fresh face, while Culberson’s record could actually hurt him. “Name me one major piece of legislation he’s accomplished in his 18 years,” Taylor says.Culberson’s record on Congress.gov includes only one major piece of legislation he sponsored that became law: the Consolidated Appropriations Act of 2012. X
Cardiac sarcoidosis affects the heart in five to 25 percent of all sarcoidosis cases, prompting a range of symptoms from none at all to an irregular heartbeat, shortness of breath, leg swelling or, in rare cases, chest pain. Because all these symptoms are indicative of many different conditions, physicians suspecting cardiac sarcoidosis typically run a battery of tests that first exclude other diseases.DIAGNOSIS: A cardiac biopsy is one of the few ways to confirm the diagnosis, although a cardiac MRI can sometimes detect the granularcells, which resemble clumps of sand or salt grains and eventually influence organ function. About one-third of the patients with cardiac sarcoidosis have detectable abnormalities visible in an echocardiogram. Other diagnostic tests include nuclear imaging and cardiac positron emission tomographic scans, also known as PET scans.Although sarcoidosis can wax and wane, cycling through active and inactive phases, it usually occurs in more than one organ at a time. Effects on the heart can range from undetectable to severe. Potential problems include abnormal heart rhythm, blood flow blockages, heart failure and valve malfunctions.TREATMENT: The primary difference when treating patients with cardiac sarcoidosis compared to most other cardiac conditions is that immunosuppressive therapy is often required in addition to standard medical and device therapy. The cornerstone for immunosuppressive therapy is corticosteroid treatment; however, steroid-sparing agents are also commonly co-administered to reduce side-effects.Cardiac device therapy has evolved over time such that many more patients are now receiving pacemakers or implantable cardiac defibrillators for primary prevention of sudden death. Steroids are used to help reduce inflammation. Prednisolone is usually used and generally needed for a course of six to 24 months.